Related Experiment Video
Updated: Aug 3, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism
Huyen Tran1, Simon McRae, Jeffrey Ginsberg
1Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario L8N 3Z5, Canada.
Insights
Venous thrombosis and thromboembolism increase with age. Anticoagulant therapy is effective for all ages but requires careful monitoring in older adults to balance bleeding risks against benefits.
Area of Science:
- Cardiology
- Geriatrics
- Hematology
Background:
- Venous thrombosis is a prevalent condition.
- Increasing mean population age correlates with a higher incidence of venous thromboembolism.
- Anticoagulant therapy offers significant benefits in reducing morbidity and mortality.
Purpose of the Study:
- To highlight the effectiveness of anticoagulant therapy across different age groups.
- To emphasize the critical need for ongoing risk-benefit assessment in elderly patients undergoing long-term oral anticoagulant therapy.
Main Methods:
- This study is a review of current understanding and clinical practice regarding venous thrombosis and its treatment.
- Analysis of existing data on anticoagulant efficacy and safety in young versus older populations.
Main Results:
- Anticoagulant therapy demonstrates equal efficacy in both younger and older patient demographics.
- The potential for substantial reduction in morbidity and mortality associated with venous thromboembolism is confirmed.
Conclusions:
- Long-term oral anticoagulant therapy is a viable option for older patients with venous thrombosis.
- Continuous evaluation is essential to ensure that the antithrombotic benefits of anticoagulation in the elderly do not get overshadowed by an increased risk of bleeding.
Abstract:
Venous thrombosis is a common disease. As the mean age of the population increases, so does the incidence of venous thromboembolism. Anticoagulant therapy is equally effective in young and older patients, and can reduce substantially the associated morbidity and mortality. When considering long-term oral anticoagulant therapy in older patients, however, careful ongoing evaluation is imperative to ensure that the risk of bleeding does not outweigh the antithrombotic benefits.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

